{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:58:34Z","timestamp":1794855514916,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00228-020-02941-w","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:02:32Z","timestamp":1593043352000},"page":"1501-1504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["What about COVID-19 and arachidonic acid pathway?"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1688-116X","authenticated-orcid":false,"given":"Malvina","family":"Hoxha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"2941_CR1","doi-asserted-by":"crossref","unstructured":"Das U (2020) Can bioactive lipids inactivate coronavirus (COVID-19)? Arch Med Res. [Google Scholar]","DOI":"10.1016\/j.arcmed.2020.03.004"},{"key":"2941_CR2","first-page":"57e66","volume":"11","author":"U Das","year":"2018","unstructured":"Das U (2018) Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: a review. J Adv Res 11:57e66 Google Scholar","journal-title":"J Adv Res"},{"key":"2941_CR3","doi-asserted-by":"publisher","unstructured":"Smeitink J, Jiang X, Pecheritsyna S, Renkema H, Van Maanen R, Beyrath J (2020) Hypothesis: mPGES-1-derived prostaglandin E2, a so far missing link in COVID-19 pathophysiology?. Preprints, 2020040180 (doi: https:\/\/doi.org\/10.20944\/preprints202004.0180.v1). [Google Scholar]","DOI":"10.20944\/preprints202004.0180.v1"},{"issue":"6485","key":"2941_CR4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.abb8034","volume":"367","author":"GA FitzGerald","year":"2020","unstructured":"FitzGerald GA (2020) Misguided drug advice for COVID-19. Science 367(6485):1434 Google Scholar","journal-title":"Science"},{"key":"2941_CR5","first-page":"266","volume":"302","author":"H Aso","year":"2012","unstructured":"Aso H, Ito S, Mori A, Morioka M, Suganuma N, Kondo M et al (2012) Prostaglandin e 2 enhances interleukin-8 production via ep4 receptor in human pulmonary microvascular endothelial cells. Am J Phys Lung Cell Mol Phys 302:266\u2013273 Google Scholar","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"2941_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.bbrc.2015.11.129","volume":"469","author":"JH Park","year":"2016","unstructured":"Park JH, Park EB, Lee JY, Min JY (2016) Identification of novel membrane-associated prostaglandin e synthase-1 (mPGES-1) inhibitors with anti-influenza activities in vitro. Biochem Biophys Res Commun 469:848\u2013855 Google Scholar","journal-title":"Biochem Biophys Res Commun"},{"key":"2941_CR7","doi-asserted-by":"crossref","unstructured":"Janssen MCH, Koene S, de Laat P, Hemelaar P, Pickkers P, Spaans E, et al. (2019) The KHENERGY study: safety and efficacy of KH176 in mitochondrial m.3243A>G spectrum disorders. Clin Pharmacol Ther . [Google Scholar]","DOI":"10.1002\/cpt.1197"},{"key":"2941_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03696-8","volume":"7","author":"S Pace","year":"2017","unstructured":"Pace S, Rossi A, Krauth V, Dehm F, Troisi F, Bilancia R et al (2017) Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation. Sci Rep 7:1\u201310 Google Scholar","journal-title":"Sci Rep"},{"key":"2941_CR9","doi-asserted-by":"crossref","unstructured":"Wu D, Mura C, Beharka AA, Han SN, Paulson KE, Hwang D, et al. (1998) Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Phys Cell Phys, 275. [Google Scholar]","DOI":"10.1152\/ajpcell.1998.275.3.C661"},{"key":"2941_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1054\/plef.2002.0430","volume":"67","author":"JN Fain","year":"2002","unstructured":"Fain JN, Kanu A, Bahouth SW, Cowan GSM, Hiler ML, Leffler CW (2002) Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins Leukot Essent Fat Acids 67:467\u2013473 Google Scholar","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"2941_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1084\/jem.20061617","volume":"204","author":"S Gross","year":"2007","unstructured":"Gross S, Tilly P, Hentsch D, Vonesch JL, Fabre JE (2007) Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. J Exp Med 204:311\u2013320 Google Scholar","journal-title":"J Exp Med"},{"key":"2941_CR12","doi-asserted-by":"crossref","unstructured":"Beyrath J, Pellegrini M, Renkema H, Houben L, Pecheritsyna S, Van Zandvoort P, et al. (2018) KH176 safeguards mitochondrial diseased cells from redox stress-induced cell death by interacting with the thioredoxin system\/peroxiredoxin enzyme machinery. Sci Rep. [Google Scholar]","DOI":"10.1038\/s41598-018-24900-3"},{"issue":"27","key":"2941_CR13","doi-asserted-by":"publisher","first-page":"E5444","DOI":"10.1073\/pnas.1704099114","volume":"114","author":"R Vijay","year":"2017","unstructured":"Vijay R, Fehr AR, Janowski AM, Athmer J, Wheeler DL, Grunewald M et al (2017) Virus-induced inflammasome activation is suppressed by prostaglandin D2\/DP1 signaling. Proc Natl Acad Sci 114(27):E5444\u2013E5453 Google Scholar","journal-title":"Proc Natl Acad Sci"},{"key":"2941_CR14","doi-asserted-by":"crossref","unstructured":"Werder R, Lynch J, Simpson J, Zhang V, Hodge N, Poh M, Blom EF, Kulis Ch, Smythe M, Upham J, et al. (2018) PGD2\/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-\u03bb production. Sci Transl Med. 10(440). [Google Scholar]","DOI":"10.1126\/scitranslmed.aao0052"},{"issue":"4","key":"2941_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/infdis\/jir804","volume":"205","author":"A Cloutier","year":"2012","unstructured":"Cloutier A, Marois I, Cloutier D, Verreault C, Cantin A, Richter M (2012) The prostanoid 15-Deoxy-\u039412,14-prostaglandin-J2 reduces lung inflammation and protects mice against lethal influenza infection. J Infect Dis 205(4):621\u2013630 Google Scholar","journal-title":"J Infect Dis"},{"key":"2941_CR16","doi-asserted-by":"crossref","unstructured":"Zheng J, Perlman S (2019) Phospholipase A2 group IID is indispensable for coronavirus-specific humoral immune memory in middle aged mice. J Immunol, 202 (1 Supplement) 140.13. [Google Scholar]","DOI":"10.4049\/jimmunol.202.Supp.140.13"},{"issue":"23","key":"2941_CR17","doi-asserted-by":"publisher","first-page":"13025","DOI":"10.1128\/JVI.01785-12","volume":"86","author":"S Xu","year":"2012","unstructured":"Xu S, Pei R, Guo M, Han Q, Lai J, Wang Y, Wu C, Zhou Y, Lu M, Chen X (2012) Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly. J Virol 86(23):13025\u201313037 Google Scholar","journal-title":"J Virol"},{"key":"2941_CR18","doi-asserted-by":"publisher","first-page":"15931","DOI":"10.1038\/s41598-017-16130-w","volume":"7","author":"M Chen","year":"2017","unstructured":"Chen M, Aoki-Utsubo C, Kameoka M et al (2017) Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane. Sci Rep 7:15931 Google Scholar","journal-title":"Sci Rep"},{"issue":"9","key":"2941_CR19","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.4049\/jimmunol.180.9.6211","volume":"180","author":"E Gaudreault","year":"2008","unstructured":"Gaudreault E, Gosselin J (2008) Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice. J Immunol 180(9):6211\u20136221 Google Scholar","journal-title":"J Immunol"},{"issue":"3","key":"2941_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1081-1206(10)63529-6","volume":"91","author":"DA Gentile","year":"2003","unstructured":"Gentile DA, Fireman P, Skoner DP (2003) Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 91(3):270\u2013274 Google Scholar","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"2941_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.rmed.2010.12.021","volume":"105","author":"H Widegren","year":"2011","unstructured":"Widegren H, Andersson M, Borgeat P, Flamand L, Johnston S, Greiff L (2011) LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects. Respir Med 105(7):997\u20131006 Google Scholar","journal-title":"Respir Med"},{"issue":"10","key":"2941_CR22","doi-asserted-by":"publisher","first-page":"6878","DOI":"10.4049\/jimmunol.175.10.6878","volume":"175","author":"MA Carey","year":"2005","unstructured":"Carey MA, Bradbury JA, Seubert JM, Langenbach R, Zeldin DC, Germolec DR (2005) Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol 175(10):6878\u20136884 Google Scholar","journal-title":"J Immunol"},{"key":"2941_CR23","doi-asserted-by":"publisher","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8","DOI":"10.1016\/S2213-2600(20)30116-8"},{"issue":"8","key":"2941_CR24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/135965350601100803","volume":"11","author":"C Amici","year":"2006","unstructured":"Amici C, Di Caro A, Ciucci A et al (2006) Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther 11(8):1021\u20131030","journal-title":"Antivir Ther"},{"key":"2941_CR25","doi-asserted-by":"publisher","first-page":"E786","DOI":"10.3390\/jcm806078631163625","volume":"8","author":"G Voiriot","year":"2019","unstructured":"Voiriot G, Philippot Q, Elabbadi A, Elbim C, Chalumeau M, Fartoukh M (2019) Risks related to the use of non-steroidal anti-inflammatory drugs in community-acquired pneumonia in adult and pediatric patients. J Clin Med 8:E786. https:\/\/doi.org\/10.3390\/jcm806078631163625","journal-title":"J Clin Med"},{"key":"2941_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1164\/rccm.201802-0229LE29461860","volume":"198","author":"D Basille","year":"2018","unstructured":"Basille D, Thomsen RW, Madsen M et al (2018) Nonsteroidal antiinflammatory drug use and clinical outcomes of community-acquired pneumonia. Am J Respir Crit Care Med 198:128\u2013131. https:\/\/doi.org\/10.1164\/rccm.201802-0229LE29461860","journal-title":"Am J Respir Crit Care Med"},{"key":"2941_CR27","unstructured":"Willsher K (2020) Antiinflammatories may aggravate COVID19 France Advises \u201cThe Guardian\u201d. [Google Scholar]"},{"key":"2941_CR28","unstructured":"European Medicines agency. EMA gives advice on the use of non- steroidal anti- inflammatories for COVID-19 [online]. 2020. Available: https:\/\/www.ema.europa.eu\/en\/news\/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19 [Accessed 24 March 2020"},{"key":"2941_CR29","unstructured":"Medicines and healthcare products regulatory agency. ibuprofen use and Coronavirus (COVID-19) [online]. 2020. Available: https:\/\/www.gov.uk\/government\/news\/ibuprofen-use-and-covid19coronavirus [accessed 24 March 2020]. [Google Scholar]"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02941-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02941-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02941-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:19:32Z","timestamp":1696285172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02941-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02941-w","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}